Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Wolfgang W. Fleischhacker"'
Autor:
Linda Levi, Mor Bar-Haim, Inge Winter-van Rossum, Michael Davidson, Stefan Leucht, Wolfgang W Fleischhacker, Jinyoung Park, John M Davis, Renè S Kahn, Mark Weiser
Publikováno v:
Schizophrenia Bulletin.
Background and Hypothesis This analysis examined the relationship between cannabis use, compliance with antipsychotics and risk for relapse in patients in remission following a first episode of schizophrenia, schizophreniform, or schizoaffective diso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba00302f25432725468b4b112a7303c5
https://doi.org/10.1093/schbul/sbad033
https://doi.org/10.1093/schbul/sbad033
Autor:
Lone Baandrup, Peter Allerup, Mette Ø. Nielsen, Signe W. Düring, Kirsten B. Bojesen, Stefan Leucht, Silvana Galderisi, Armida Mucci, Paola Bucci, Celso Arango, Covadonga M. Díaz‐Caneja, Paola Dazzan, Philip McGuire, Arsime Demjaha, Bjørn H. Ebdrup, Wolfgang W. Fleischhacker, René S. Kahn, Birte Y. Glenthøj
Publikováno v:
Baandrup, L, Allerup, P, Nielsen, M Ø, Düring, S W, Bojesen, K B, Leucht, S, Galderisi, S, Mucci, A, Bucci, P, Arango, C, Díaz-Caneja, C M, Dazzan, P, McGuire, P, Demjaha, A, Ebdrup, B H, Fleischhacker, W W, Kahn, R S & Glenthøj, B Y 2022, ' Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models ', Acta Psychiatrica Scandinavica, vol. 146, no. 1, pp. 21-35 . https://doi.org/10.1111/acps.13434
Baandrup, L, Allerup, P, Nielsen, M, Düring, S W, Bojesen, K B, Leucht, S, Galderisi, S, Mucci, A, Bucci, P, Arango, C, Díaz-Caneja, C M, Dazzan, P, McGuire, P, Demjaha, A, Ebdrup, B H, Fleischhacker, W W, Kahn, R S & Glenthøj, B Y 2022, ' Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models ', Acta Psychiatrica Scandinavica, vol. 146, no. 1, pp. 21-35 . https://doi.org/10.1111/acps.13434
Baandrup, L, Allerup, P, Nielsen, M, Düring, S W, Bojesen, K B, Leucht, S, Galderisi, S, Mucci, A, Bucci, P, Arango, C, Díaz-Caneja, C M, Dazzan, P, McGuire, P, Demjaha, A, Ebdrup, B H, Fleischhacker, W W, Kahn, R S & Glenthøj, B Y 2022, ' Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models ', Acta Psychiatrica Scandinavica, vol. 146, no. 1, pp. 21-35 . https://doi.org/10.1111/acps.13434
Objective: Historically, assessment of the psychometric properties of the Positive and Negative Syndrome Scale (PANSS) has had several foci: (1) calculation of reliability indexes, (2) extraction of subdimensions from the scale, and (3) assessment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e57d0ba33bedae07bcff68e6b76b9d6
https://curis.ku.dk/ws/files/313158672/Acta_Psychiatr_Scand_2022_Baandrup_Scalability_of_the_Positive_and_Negative_Syndrome_Scale_in_first_u2010episode.pdf
https://curis.ku.dk/ws/files/313158672/Acta_Psychiatr_Scand_2022_Baandrup_Scalability_of_the_Positive_and_Negative_Syndrome_Scale_in_first_u2010episode.pdf
Autor:
René S Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shon W Lewis, Marion Leboyer, Celso Arango, Paola Dazzan, Richard Drake, Stephan Heres, Covadonga M Díaz-Caneja, Dan Rujescu, Mark Weiser, Silvana Galderisi, Birte Glenthøj, Marinus J C Eijkemans, W Wolfgang Fleischhacker, Shitij Kapur, Iris E Sommer, Inge Winter-van Rossum, Metten Somers, Paula C Ywema, Shitisj Kapur, Andreas Meyer-Lindenberg, Wolfgang W Fleischhacker, Anne Lotte Meijering, Jocelyn Petter, Resy Van de Brug, Joost Schotsman, Jildou Zwerver, Jos Peuskens, Marc De Hert, Erik Thys, Lucho G Hranov, Valentin Hranov, Jan Libiger, Richard Köhler, Pavel Mohr, Birte Glenthoj, Brian Broberg, Signe Düring, Lone Baandrup, Stephane Jamain, Ina Giegling, Mor Bar Heim, Michael Davidson, Paola Bucci, Armida Mucci, Janusz Rybakowski, Agnieszka Remlinger-Molenda, Ilan Gonen, Paull Radu, Marina Díaz-Marsá, Alberto Rodriguez, Tomas Palomo, Roberto Rodriguez-Jimenez, Paz García-Portilla, Miquel Bernardo, Julio Bobes, Christina Vilares Oliveira, Gregor Berger, Claudia Wildt, Roccio Perez-Iglesias, Sarah Gregory, Danielle Wilson
Publikováno v:
The Lancet Psychiatry, 5(10), 797. Elsevier Limited
McGuire, P & Dazzan, P 2018, ' Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE) : a three-phase switching study ', The lancet. Psychiatry, vol. 5, no. 10, pp. 797-807 . https://doi.org/10.1016/S2215-0366(18)30252-9
The Lancet. Psychiatry, 5(10), 797-807. ELSEVIER SCI LTD
McGuire, P & Dazzan, P 2018, ' Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE) : a three-phase switching study ', The lancet. Psychiatry, vol. 5, no. 10, pp. 797-807 . https://doi.org/10.1016/S2215-0366(18)30252-9
The Lancet. Psychiatry, 5(10), 797-807. ELSEVIER SCI LTD
BACKGROUND: No established treatment algorithm exists for patients with schizophrenia. Whether switching antipsychotics or early use of clozapine improves outcome in (first-episode) schizophrenia is unknown.METHODS: This three-phase study was done in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5a2a19dd5e39afa4153416617ec0a0
https://doi.org/10.1016/S2215-0366(18)30252-9
https://doi.org/10.1016/S2215-0366(18)30252-9
Autor:
Silvana, Galderisi, Michael, Davidson, René S, Kahn, Armida, Mucci, Han, Boter, Mihai D, Gheorghe, Janusz K, Rybakowski, Jan, Libiger, Sonia, Dollfus, Juan J, López-Ibor, Joseph, Peuskens, Luchezar G, Hranov, Wolfgang W, Fleischhacker, U, Gschwandtner
Publikováno v:
Schizophrenia Research. 115:104-114
Background: Profile and correlates of cognitive deficits in first episode (FE) schizophrenia patients are still debated. The present study is aimed to clarify in a large sample of FIE patients the extent of impairment in key cognitive domains and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a6de0c00352085b25218a5e394aeee
https://doi.org/10.1016/j.schres.2009.09.022
https://doi.org/10.1016/j.schres.2009.09.022
Publikováno v:
Psychopharmacology. 162:82-84
RATIONALE: Placebo-controlled trials (PCTs) are still regulatory requirements for the licensing of new drugs. Most recent phase II and phase III PCTs of antipsychotics in schizophrenia have been conducted outside Europe. This development needs to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457be8c4d881fe7cc59cd0466cfe20cb
https://doi.org/10.1007/s00213-002-1060-z
https://doi.org/10.1007/s00213-002-1060-z
Autor:
Wolfgang W, Fleischhacker
Publikováno v:
World psychiatry : official journal of the World Psychiatric Association (WPA). 6(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5bcf4c0cb9cda13403e3336609dcfaf
https://pubmed.ncbi.nlm.nih.gov/17342221
https://pubmed.ncbi.nlm.nih.gov/17342221
Autor:
Josef K, Hinterhoelzl, Kayvon, Salimi, Christian, Humpel, Nicolas, Singewald, Christine, Adlassnig, Reiner, Fischer-Colbrie, Wolfgang W, Fleischhacker, Josef, Marksteiner
Publikováno v:
Journal of neurochemistry. 87(1)
Phencyclidine (PCP) is a non-competitive NMDA glutamate receptor antagonist that induces psychotomimetic effects in humans and experimental animals. Chronic PCP exposure elicits signs of persistently altered frontal brain activity and related behavio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9f7b41f24aca1547f4c7bfc0b76ebbc
https://pubmed.ncbi.nlm.nih.gov/12969248
https://pubmed.ncbi.nlm.nih.gov/12969248
Autor:
Martinuzzi E; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Barbosa S; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Daoudlarian D; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Ali WBH; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France., Gilet C; Université Côte d'Azur, Centre National de la Recherche Scientifique, Laboratoire Informatique Signaux et Systèmes de Sophia Antipolis, Sophia Antipolis, France., Fillatre L; Université Côte d'Azur, Centre National de la Recherche Scientifique, Laboratoire Informatique Signaux et Systèmes de Sophia Antipolis, Sophia Antipolis, France., Khalfallah O; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Troudet R; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France., Jamain S; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France., Fond G; Assistance Publique Hôpitaux de Marseille, Marseille, France., Sommer I; Department of Neuroscience and Department of Psychiatry, University Medical Center Groningen, Rijks Universiteit Groningen, Groningen, The Netherlands.; Department of Medical and Biological Psychology, University of Bergen, Bergen, Norway., Leucht S; Department of Psychiatry and Psychotherapy, Technische Universität München, München, Germany.; Department of Psychosis Studies, Institute of Psychiatry, National Institute for Health Research, Mental Health Biomedical Research Centre, King's College London, London, UK., Dazzan P; Department of Psychosis Studies, Institute of Psychiatry, National Institute for Health Research, Mental Health Biomedical Research Centre, King's College London, London, UK., McGuire P; Department of Psychosis Studies, Institute of Psychiatry, National Institute for Health Research, Mental Health Biomedical Research Centre, King's College London, London, UK., Arango C; Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Diaz-Caneja CM; Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Fleischhacker W; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Medical University Innsbruck, Innsbruck, Austria., Rujescu D; Department of Psychiatry, University of Halle, Halle, Germany., Glenthøj B; Faculty of Health and Medical Sciences, Center for Neuropsychiatric Schizophrenia Research and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Psychiatric Hospital Center Glostrup, University of Copenhagen, Copenhagen, Denmark., Winter I; Department of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands., Kahn RS; Department of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands., Yolken R; John Hopkins School of Medicine, The John Hopkins Hospital, Baltimore, USA., Lewis S; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic. Health Sciences Centre (MAHSC), University of Manchester, Manchester, UK., Drake R; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic. Health Sciences Centre (MAHSC), University of Manchester, Manchester, UK., Davidovic L; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Leboyer M; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France. marion.leboyer@inserm.fr.; Assistance Publique Hôpitaux de Paris, Pole de Psychiatrie et Addictologie, Hopitaux Universitaires Henri Mondor, Créteil, France. marion.leboyer@inserm.fr.; Fondation Fondamental, Hôpital Albert Chenevier Pôle de Psychiatrie, Créteil, France. marion.leboyer@inserm.fr., Glaichenhaus N; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France. nicolas.glaichenhaus@unice.fr.; Fondation Fondamental, Hôpital Albert Chenevier Pôle de Psychiatrie, Créteil, France. nicolas.glaichenhaus@unice.fr.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2019 Jun 21; Vol. 9 (1), pp. 171. Date of Electronic Publication: 2019 Jun 21.
Autor:
Fleischhacker W; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck, Innsbruck, Austria., Galderisi S; Department of Psychiatry, University of Naples (SUN), Naples, Italy., Laszlovszky I; Medical Division, Gedeon Richter Plc, Budapest, Hungary. Electronic address: i.laszlovszky@richter.hu., Szatmári B; Medical Division, Gedeon Richter Plc, Budapest, Hungary., Barabássy Á; Medical Division, Gedeon Richter Plc, Budapest, Hungary., Acsai K; Medical Division, Gedeon Richter Plc, Budapest, Hungary., Szalai E; Medical Division, Gedeon Richter Plc, Budapest, Hungary., Harsányi J; Medical Division, Gedeon Richter Plc, Budapest, Hungary., Earley W; Allergan, Madison, NJ, USA., Patel M; Allergan, Madison, NJ, USA., Németh G; Medical Division, Gedeon Richter Plc, Budapest, Hungary.
Publikováno v:
European psychiatry : the journal of the Association of European Psychiatrists [Eur Psychiatry] 2019 May; Vol. 58, pp. 1-9. Date of Electronic Publication: 2019 Feb 07.
Autor:
Martinuzzi E; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Barbosa S; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Daoudlarian D; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Bel Haj Ali W; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France., Gilet C; Université Côte d'Azur, Centre National de la Recherche Scientifique, Laboratoire Informatique Signaux et Systèmes de Sophia Antipolis, Sophia Antipolis, France., Fillatre L; Université Côte d'Azur, Centre National de la Recherche Scientifique, Laboratoire Informatique Signaux et Systèmes de Sophia Antipolis, Sophia Antipolis, France., Khalfallah O; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Troudet R; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France., Jamain S; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France., Fond G; Assistance Publique Hôpitaux de Marseille, Marseille, France., Sommer I; Department of Neuroscience and Department of Psychiatry, University Medical Center Groningen, Rijks Universiteit Groningen, Groningen, The Netherlands.; Department of Medical and Biological Psychology, University of Bergen, Bergen, Norway., Leucht S; Department of Psychiatry and Psychotherapy, Technische Universität München, München, Germany.; Department of Psychosis Studies, Institute of Psychiatry, National Institute for Health Research, Mental Health Biomedical Research Centre, King's College London, London, UK., Dazzan P; Department of Psychosis Studies, Institute of Psychiatry, National Institute for Health Research, Mental Health Biomedical Research Centre, King's College London, London, UK., McGuire P; Department of Psychosis Studies, Institute of Psychiatry, National Institute for Health Research, Mental Health Biomedical Research Centre, King's College London, London, UK., Arango C; Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Diaz-Caneja CM; Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Fleischhacker W; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Medical University Innsbruck, Innsbruck, Austria., Rujescu D; Department of Psychiatry, University of Halle, Halle, Germany., Glenthøj B; Faculty of Health and Medical Sciences, Center for Neuropsychiatric Schizophrenia Research and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Psychiatric Hospital Center Glostrup, University of Copenhagen, Copenhagen, Denmark., Winter I; Department of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands., Kahn RS; Department of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, The Netherlands., Yolken R; John Hopkins School of Medicine, The John Hopkins Hospital, Baltimore, USA., Lewis S; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic. Health Sciences Centre (MAHSC), University of Manchester, Manchester, UK., Drake R; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic. Health Sciences Centre (MAHSC), University of Manchester, Manchester, UK., Davidovic L; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France., Leboyer M; Université Paris Est Créteil, Faculté de Medicine Institut, National de la Santé et de la Recherche Médicale, Créteil, France. marion.leboyer@inserm.fr.; Assistance Publique Hôpitaux de Paris, Pole de Psychiatrie et Addictologie, Hopitaux Universitaires Henri Mondor, Créteil, France. marion.leboyer@inserm.fr.; Fondation Fondamental, Hôpital Albert Chenevier Pôle de Psychiatrie, Créteil, France. marion.leboyer@inserm.fr., Glaichenhaus N; Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France. nicolas.glaichenhaus@unice.fr.; Fondation Fondamental, Hôpital Albert Chenevier Pôle de Psychiatrie, Créteil, France. nicolas.glaichenhaus@unice.fr.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2019 Jan 17; Vol. 9 (1), pp. 20. Date of Electronic Publication: 2019 Jan 17.